LivaNova Execs to Present at High-Profile Healthcare Conferences
Event summary
- LivaNova PLC will present at Morgan Stanley and Baird healthcare conferences on Sept. 14 and 15, 2026.
- CEO Vladimir Makatsaria, CFO Alex Shvartsburg, and Chief Strategy Officer Philip Kowalczyk will participate in a fireside chat at Morgan Stanley.
- Chief Innovation Officer Ahmet Tezel will join Makatsaria and Shvartsburg at the Baird conference.
- Webcasts will be available via LivaNova’s website, with replays posted within 24 hours.
The big picture
LivaNova’s participation in back-to-back high-profile healthcare conferences underscores its push to engage with investors and analysts amid evolving industry dynamics. The company, which operates in the competitive neurological and cardiac device sectors, is likely using these platforms to reinforce its strategic vision and address market challenges. With approximately 3,300 employees and a global footprint, LivaNova’s messaging will be closely watched for signals on execution and differentiation.
What we're watching
- Strategic Messaging
- How LivaNova frames its neurological and cardiac solutions could signal shifts in R&D focus or market expansion.
- Investor Sentiment
- Whether the presentations address near-term financial pressures or long-term growth initiatives will shape investor expectations.
- Competitive Positioning
- The emphasis on innovation and corporate strategy may hint at how LivaNova plans to differentiate itself in a crowded med-tech landscape.